Richard Whitley to Hepatitis C, Chronic
This is a "connection" page, showing publications Richard Whitley has written about Hepatitis C, Chronic.
Connection Strength
0.060
-
A randomized, open-label study to evaluate the safety and pharmacokinetics of human hepatitis C immune globulin (Civacir) in liver transplant recipients. Liver Transpl. 2005 Aug; 11(8):941-9.
Score: 0.060